Intellia Therapeutics Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

NTLA Stock  USD 13.80  0.68  5.18%   
Intellia Therapeutics cycle indicators tool provides the execution environment for running the Hilbert Transform Dominant Cycle Period indicator and other technical functions against Intellia Therapeutics. Intellia Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Dominant Cycle Period indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Intellia Therapeutics price series.

Indicator
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Intellia Therapeutics price series in order to analyze variations of the instantaneous cycles.

Intellia Therapeutics Technical Analysis Modules

Most technical analysis of Intellia Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Intellia from various momentum indicators to cycle indicators. When you analyze Intellia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Intellia Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intellia Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intellia Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Intellia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intellia Therapeutics's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Intellia Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Intellia Therapeutics, we also check how macroeconomic factors affect Intellia Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding22.4326.39366.82385.16
PTB Ratio8.062.172.582.74
Hype
Prediction
LowEstimatedHigh
9.3113.6517.99
Details
Intrinsic
Valuation
LowRealHigh
12.4230.9335.27
Details
Naive
Forecast
LowNextHigh
8.7513.1017.44
Details
30 Analysts
Consensus
LowTargetHigh
75.7683.2592.41
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intellia Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intellia Therapeutics' short interest history, or implied volatility extrapolated from Intellia Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Casinos Idea
Casinos
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested over 40 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Intellia Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intellia Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intellia Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intellia Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Intellia Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intellia Therapeutics. If investors know Intellia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intellia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.45)
Revenue Per Share
0.449
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.28)
Return On Equity
(0.52)
The market value of Intellia Therapeutics is measured differently than its book value, which is the value of Intellia that is recorded on the company's balance sheet. Investors also form their own opinion of Intellia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Intellia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intellia Therapeutics' market value can be influenced by many factors that don't directly affect Intellia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intellia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Intellia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intellia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.